US Patent Issued to Bristol-Myers Squibb on Sept. 30 for "Pyrimidinones as factor XIA inhibitors" (New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,421, issued on Sept. 30, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Pyrimidinones as factor XIA inhibitors" was invented by Andrew K. Dilger (Ewing, N.J.), James R. Corte (Yardley, Pa.), Indawati De Lucca (Pennington, N.J.), Tianan Fang (Newtown, Pa.), Wu Yang (Princeton Junction, N.J.), Yufeng Wang (Belle Mead, N.J.), Kumar Balashanmuga Pabbisetty (Piscataway, N.J.), William R. Ewing (Yardley, Pa.), Yeheng Zhu (Stockton, N.J.), Ruth R. Wexler (Belle Mead, N.J.), Donald J. P. Pinto (Churchville, Pa.), Michael J. Orwat (New Hope, Pa.) and Leon M. Smith II (Somerset, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present in...